Nevakar

Nevakar is a specialty pharmaceutical company that focuses on the development of innovative products in the injectable and ophthalmic space.

Funding reportedLast round: Private equity

BiopharmaBridgewater, United States

Follow Nevakar and see its new rounds in your feed.Start following

What company datasets say Nevakar raised

Funding, as reported

Reported in all$135Min dollars

Rounds3

Last roundPrivate equity

Last round dateJun 2019

Investors listed3

SEC Form D$16M sold, 2 filings, last Aug 2023

From the SEC filings it signed: 3 on the team.

On the board, as filediAlex SissonGeorge ZorichRam PottiRon Wooten

Investors who name them

Each firm lists Nevakar on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

Startups like it

Add your raise, your deck and your story, and put Nevakar in front of investors. Or tell us what we have wrong.